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ABSTRACT  We have previously characterized a monoclonal antibody, $12, that binds only to 
activated platelets  (McEver,  R. P., and M. N. Martin,  1984, J.  Biol.  Chem., 259:9799-9804). It 
identifies a platelet membrane protein of Mr 140,000, which we have designated as GMP-140. 
Using  immunocytochemical  techniques we  have  now  localized  this protein  in  unstimulated 
and thrombin-stimulated  platelets.  Polyclonal antibodies to  purified  GMP-140 were  used to 
enhance  the  sensitivity  of  detection.  Nonpermeabilized,  unstimulated  platelets,  incubated 
with  anti-GMP-140  antibodies, and then with  IgG-gold  probes,  showed  very  little  label  for 
GMP-140 along their plasma membranes.  In contrast, thrombin-stimulated  platelets  exhibited 
at least a 50-fold increase in the amount of label along the plasma membrane. On frozen thin 
sections  of  unstimulated  platelets  we  observed  immunogold  label  along the  alpha-granule 
membranes.  We also employed the more sensitive technique of permeabilizing with saponin 
unstimulated platelets  in suspension,  and then incubating the cells with polyclonal anti-GMP- 
140  antibodies  and  Fab-peroxidase  conjugate.  Alpha-granule  membranes  showed  heavy 
reaction product, but no other intracellular organelles were specifically labeled.  These results 
demonstrate that GMP-140  is an alpha-granule  membrane  protein that is expressed  on the 
platelet plasma membrane during degranulation. 
Activated blood platelets undergo  a  complex series of bio- 
chemical and morphological changes that promote their he- 
mostatic role at sites of vascular injury. Many of  these changes 
occur at the platelet surface. For example, the local generation 
of thrombin stimulates platelet secretion and aggregation, as 
well as fibrin formation (1).  The binding of fibrinogen, von 
Willebrand  factor, thrombospondin,  and  fibronectin to  the 
surface of  the activated platelet promotes cell-cell interactions 
and adhesion of platelets to subendothelial surfaces (2). Factor 
XIIIa binds to thrombin-activated platelets, where it may be 
localized for efficient cross-linking of fibrin polymers into a 
stable  clot  (3).  The  molecular events responsible  for these 
diverse interactions at the surfaces of activated platelets are 
incompletely defined but thought to involve changes in the 
conformation or rearrangements of platelet membrane gly- 
coproteins. 
We recently described a monoclonal antibody, S12, which 
reacts minimally with unstimulated human platelets but binds 
to -10,000 sites/cell after platelets have been activated with 
thrombin (4).  We isolated the protein recognized by S12  by 
affinity  chromatography  of  Lubrol  PX-solubilized  human 
platelet  membranes  on  S l2-agarose.  As  analyzed  by  SDS 
PAGE, the unreduced protein has an Mr of 138,000,  and the 
reduced protein has an Mr of 148,000.  The slower mobility 
of the reduced protein presumably reflects unfolding of the 
polypeptide after cleavage of intrachain disulfide bonds. The 
molecule appears to be glycosylated, since it stains with peri- 
odic acid-Schiff. 
In our earlier report (4), we suggested two possible reasons 
for the enhanced binding of S 12 to platelets after thrombin 
activation.  The  first  hypothesis  was  that  the  S12-binding 
protein is located in the plasma membrane of unstimulated 
platelets but is inaccessible to antibody. Thrombin activation 
"unmasks" the protein, either by a change in its conformation 
that allows expression of the antigen identified by S12  or by 
rearrangement of other membrane proteins that interfere with 
antibody access to the  antigen.  The  second hypothesis was 
that the protein is localized to a secretory-granule membrane 
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induced secretion from the platelet. We now report the local- 
ization of the S 12-binding protein in unstimulated and throm- 
bin-stimulated human  platelets by three immunocytochemi- 
cat techniques. Our data  support the second hypothesis and 
indicate  that  the  protein  is  localized  exclusively  in  alpha- 
granule membranes in the unstimulated platelet. After throm- 
bin stimulation and membrane  fusion, the protein is redistri- 
buted  to  the  surface-connected  canalicular  system  (SCCS) 1 
and plasma membrane. Because of its distinct localization in 
the  unstimulated  cell,  we  have  given this protein  the desig- 
nation  GMP-140,  indicating that  it  is  a  granule  membrane 
protein with a  molecular weight of ~  140,000. 
MATERIALS  AND  METHODS 
Preparation of Antibodies:  Purified monoclonal Sl2 lgO was pre- 
pared as previously described (4). Platelet GMP-140, isolated by S12 affinity 
chromatography, was used to raise polyclonal antibodies in rabbits. GMP-140 
was denatured  by heating at  100*C for 5 min in the presence of 1%  SDS. 
Rabbits were injected subcutaneously with 50 ~g of either nondenatured  or 
SDS-denatured GMP-140 emulsified in complete Freund's adjuvant.  After 4 
wk the rabbits were boosted subcutaneously with 50 ug of the same immunogen 
emulsified in incomplete Freund's adjuvant. They were bled 1 wk later. 
The specificities of the polyclonal antibodies were examined by immuno- 
blotting. 50-ug samples ofplatelet protein, solubilized in 2% SDS in the absence 
of reducing agent, were electrophoresed in parallel lanes of a 7-15% exponential 
polyacrylamide slab gel (5). then transferred to nitrocellulose paper (6). After 
the paper had been immersed in l0 mM NaPO4, 0.15 M NaCI, pH 7.5, 0.05% 
(vol/vol)  Tween 20,  strips containing  individual  lanes of separated platelet 
proteins were incubated with nonimmune or immune sera (1:1,000 dilution in 
10 mM NaPO4, 0.15 M NaCI, pH  7.5, 0.05% (vol/vol) Tween 20) for 1 h at 
room temperature, then washed three times with 10 mM NaPO4, 0.15 M NaCI, 
pH 7.5, 0.05% (vol/vol) Tween 20. Bound antibody was then detected with an 
enzyme-linked immunosorbent assay system (Vectastain, Vector Laboratories, 
Inc., Burlingame, CA) consisting of sequential additions of biotinylated goat 
anti-rabbit antibody, an avidin-biotinylated  horseradish peroxidase complex, 
and a color-developing substrate, 4-chloro-l-napthol. 
Triton X- 1 14 Extraction:  Platelet membrane proteins were extracted 
with Triton  X-114 as described by  Bordier (7). Crude  platelet  membranes 
prepared by freeze-thawing and sonication were lysed at 4"C in 10 mM Tris- 
HCI, pH 7.4, 150 mM NaCI, 1 mM EDTA, 1 mM PMSF, 1 mM iodoacetamide, 
1% Triton X-114. After the protein concentration was adjusted to 0.5 mg/ml, 
the aqueous and detergent phases were separated (7). The relative amount of 
GMP-140 in each phase was then determined by immunoblotting as described 
above, except that bound antibody was detected by incubating the nitrocellulose 
sheet with J2~l-protein  A (90,000 cpm/ml). The nitrocellulose was then washed, 
dried, and subjected to autoradiography (4). 
Preparation  of  Platelets  for  Immunocytochemical  Stud- 
ies:  Platelets  dripped into fixative were  prepared  from the blood of normal 
patients  as described previously (8). Washed, unstimulated,  and thrombin- 
stimulated  (1  U/ml  for  5  rain)  platelets  were also  prepared  as  described 
previously (9). EDTA (1 mM) was added to the platelet resuspension buffer to 
minimize  cell clumping.  Samples were fixed in  2%  paraformaldehyde  with 
0.05% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, for 1 h at 37"C. 
Immunocytochemical  Procedures:  lmmunocytochemical  pro- 
cedures  on  frozen  thin  sections  and  on  suspensions  of nonpermeabilized 
platelets  using  IgG-colloidal gold  (5-nm)  probes  (Janssen  Pharmaceutica, 
Beerse, Belgium) were performed as described previously (8, 9). When sections 
were incubated with polyclonal antibodies, the probe was colloidal gold con- 
jugated  with goat  anti-rabbit IgG; for sections incubated  with  monoclonal 
antibody, the probe was colloidal gold conjugated with goat anti-mouse IgG. 
Immunocytochemical procedures on saponin-permeabilized platelets were per- 
formed as previously described (8, 9). 
Control  measures  for all  procedures  included  the substitution  of buffer, 
preimmune rabbit serum, or purified mouse IgG for specific primary antibody. 
RESULTS 
Fig.  1  A  illustrates the reactivity of polyclonal antibodies pre- 
Abbreviation  used in this paper:. SCCS, surface-connected canalicu- 
lar system. 
pared against nondenatured GMP-140 as assessed by immu- 
noblotting of platelet proteins.  Similar results were obtained 
with  antibodies  raised  against  SDS-denatured  protein,  To 
illustrate the specificity of the anti-GMP-140 antibodies, im- 
munoblotting was also performed in parallel with antibodies 
to GP  lib, another membrane  glycoprotein,  which  migrates 
near GMP-140  in SDS gels. Antibodies to GMP-140  reacted 
with a  single protein of Mr  140,000,  which  migrates slightly 
faster than  GP  lib under nonreducing conditions.  The  mo- 
bility of this protein relative to GP  lib is identical to that of 
purified  GMP-140  (4).  The  monoclonal  antibody  S12  also 
reacted with a  protein of identical mobility in the immuno- 
blotting procedure (not shown). Therefore, both S12 and the 
polyclonal antibodies identify the same molecule. Neither S 12 
nor the polyclonal antibodies bound to GMP- 140 after plate- 
let  proteins  had  been  electrophoresed  in  the  presence  of 
reducing agent. 
GMP-140  was  initially  isolated  from  a  Lubrol  (Sigma 
Chemical  Co.,  St.  Louis,  MO)-PX  lysate  of platelet  mem- 
branes (4), which suggests that it is a  membrane  protein. To 
define  further the  physical  properties  of GMP-140,  we  ex- 
tracted platelet membrane proteins at 4"C with Triton X-114 
FIGURE  |  (A) Immunoblotting of platelet proteins with polyclonal 
antibodies to GMP-140.  SDS extracts of platelets were electropho- 
resed in nonreduced SDS-polyacrylamide gels, transferred to nitro- 
cellulose paper, and incubated with nonimmune or immune sera, 
and bound antibody was detected by an enzyme-linked immuno- 
sorbent assay. Lane  I, nonimmune sera; lane 2, anti-glycoprotein 
lib  antibodies;  lane  3,  anti-GMP-140  antibodies. Antibodies  to 
GMP-140 reacted with a single  protein of Mr  140,000,  which mi- 
grates slightly faster than glycoprotein lib under nonreducing con- 
ditions. (B)  Evidence  for the amphipathic character of GMP-140. 
40 pg platelet membrane protein was extracted with Triton X-114. 
The detergent and aqueous phases were recovered and analyzed 
by immunoblotting with anti-GMP-140 antibodies as in A,  except 
that ~2Sl-protein A was used  to detect bound antibody. Note that 
GMP-140 is markedly enriched in the detergent phase (lane 2) and 
depleted in the aqueous phase (lane  1  ). 
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temperature, then  analyzed each phase by immunoblotting 
with anti-GMP-140 antibodies. As shown in Fig.  1  B, GMP- 
140 was highly enriched in the detergent phase and depleted 
in the aqueous phase. This indicates that GMP-140 has am- 
phipathic properties and further suggests that it is an integral 
membrane protein. 
In preliminary studies, we determined that the sensitivity 
of immunocytochemical detection  of GMP-140  was much 
greater with the polyclonal antibodies than with the monoclo- 
hal  antibody  S12.  This  presumably reflects the  binding of 
more than one polyclonal antibody to each GMP-140 mole- 
cule or greater affinity of some polyclonal antibody molecules 
for  the  platelet  protein.  We  have  therefore  presented  the 
polyclonal antibody data, although the S 12 results were iden- 
tical in all cases except for reduced labeling intensity. 
Previous biochemical results (4) indicated that the binding 
of the monoclonal antibody S12  to platelets is dramatically 
enhanced after the platelets have been activated with throm- 
bin.  We  first  investigated  this  finding  morphologically by 
incubating  suspensions  of nonpermeabilized  platelets  with 
antibodies to SDS-denatured GMP-140, and comparing the 
labeling with immunogold probes in unstimulated and throm- 
bin-stimulated platelets. Unstimulated platelets, whether im- 
mediately fixed or washed, showed little label on the plasma 
membrane (Fig.  2).  Thrombin-stimulated platelets,  in  con- 
trast, showed at least a 50-fold increase in label on the plasma 
membrane (Fig.  3).  Similar results were obtained with anti- 
bodies to nondenatured GMP-140 (not shown). 
We next determined whether the increase in labeling of the 
protein  on  the  platelet  surface after thrombin  stimulation 
reflected a conformational change in GMP-140, or rearrange- 
ment  of other  membrane proteins,  either  of which  might 
allow expression ofGMP-140; or the movement of  the protein 
from an intracellular location to the plasma membrane. To 
answer this question,  we used immunocytochemical proce- 
dures on frozen thin sections of unstimulated platelets, thus 
eliminating the problem of penetration of the cell by immu- 
noreagents.  Sections  incubated  with  polyclonal  antibodies 
prepared  against  denatured  or  nondenatured  GMP-140 
showed immunogold label along alpha-granule membranes 
(Fig.  4a).  Occasionally  the  granule  membrane  bilayer  is 
cleaved on frozen thin sections in a manner similar to freeze- 
fractured membranes. When this occurred, we could clearly 
detect the label within the inner granule membrane (Fig. 4 b). 
Other  intracellular  structures  were  also  labeled  (Fig.  4c). 
These structures may be extracted alpha-granules. However, 
since the dense (serotonin-containing) granule cannot be iden- 
tified on frozen sections (8,  9) we cannot rule out the possi- 
bility that its membrane also contains this antigen. Of a total 
of 92 platelets, we observed 73% of the immunogold particles 
over granules, 5% over plasma membrane, and 22% over the 
cell cytoplasm. 
When we used the more sensitive technique of permeabil- 
izing with saponin unstimulated platelets in suspension and 
then incubating the cells with polyclonal antibodies to non- 
denatured GMP-140 and Fab-peroxidase conjugate, we ob- 
served  heavy  reaction  product  along  many  alpha-granule 
membranes (Fig. 4d). No other intracellular organelles were 
specifically labeled; some alpha-granules showed no reaction 
product (Fig. 4 d). 
Since the  technique  used  to  examine the  localization  of 
antigen on thrombin-stimulated platelets did not allow visu- 
alization of internal sites (Fig.  3),  frozen thin  sections were 
also studied. These sections showed that 5 min after thrombin- 
stimulated degranulation  had occurred,  most of the  GMP- 
140 had been redistributed from the alpha-granule membrane 
to the SCCS and plasma membrane (Fig. 5). 
DISCUSSION 
We have demonstrated by immunocytochemical procedures 
that  a  glycoprotein detected  on  the  plasma  membrane of 
thrombin-stimulated  platelets  is  localized  to  alpha-granule 
membranes in unstimulated cells. This protein, when electro- 
phoresed  on  SDS-polyacrylamide gels  in  the  presence  or 
absence of reducing  agent,  has  mobilities  similar to  those 
previously reported for glycoprotein IIa, a platelet membrane 
protein of unknown function (10,  l 1). However, since more 
than one protein may have similar mobilities, depending on 
the gel system employed, we have given this protein (a granule 
membrane protein of Mr 140,000)  the designation GMP-140 
to  indicate  its  distinct  subeellular  localization.  GMP-140, 
which is localized in the membrane of alpha-granules, differs 
from secretory proteins such as fibrinogen and PF4,  which 
are packaged within alpha granules (8,  9,  12). Shu-Chun et 
al. have described a monoclonal antibody named KC4, with 
properties similar to those  of Sl2  (13).  Subsequent  experi- 
ments have indicated  that  KC4  and  S12  identify different 
epitopes on the same platelet protein (Berman, C., B. Furie, 
B. C. Furie, and R. P. McEver, unpublished observations). 
Other investigators have analyzed the protein composition 
of platelet secretory granule, or internal membranes by sub- 
cellular fractionation followed by SDS PAGE or crossed im- 
munoelectrophoresis ( 14-18). Using human platelets, Gogs- 
tad et al. (14,  15) isolated an alpha-granule-rich fraction that 
contained a number of membrane-associated proteins, includ- 
ing two antigens thought to be unique to alpha-granules. Carry 
et al.  (19) and Fishkes and  Rudnick (20)  have identified a 
proton-translocating ATPase in a dense granule fraction from 
porcine platelets, but the enzyme has not been isolated, nor 
FIGURES  2 and 3  Fig.  2: Transmission  electron micrograph of washed, unstimulated platelets, fixed and processed  immunocy- 
tochemically for  the  extracellular distribution of  GMP-140.  Platelets  were  exposed to  anti-GMP-140  polyclonal antibodies 
produced against SDS-denatured  GMP-140,  and then to immunogold conjugate. Note that there is only a small amount of label 
on the plasma membranes of these cells (arrowheads). Similar results were obtained with antibodies produced against nondena- 
tured GMP-140.  x  48,000.  Fig. 3: Transmission  electron micrograph of thrombin-stimulated (1  U/ml) platelets fixed 5 min after 
thrombin activation and examined immunocytochemically for the extracellular distribution of GMP-140 as in  Fig. 2. A  large 
amount of immunogold label is observed on the surfaces of these cells (arrowheads) as compared with the unstimulated platelets 
in Fig. 2. Note that the membranes of many vacuolar-appearing  structures are also labeled (asterisks). However, since these cells 
have not been permeabilized, these structures must be continuous with the extracellular space, and probably represent dilated 
channels of the SCCS. Other such structures  are unlabeled and are probably not yet continuous with the external space. EDTA 
(1 mM) was added to the platelet resuspension  buffer to minimize cell clumping after activation with thrombin, x  48,000. 
STENBERG ET  AL.  Platelet Granule  Membrane Protein  883 FIGURE 4  Frozen  thin  sections  (a-c)  of unstimulated platelets  exposed to  polyclonal antibodies to  GMP-140,  followed by 
immunogold conjugate.  (a)  Note the extensive  label along alpha-granule  membranes (arrowheads). Plasma membrane label is 
insignificant.  The apparent cytoplasmic labeling may reflect  granule  membranes that are obliquely sectioned  and  not clearly 
visualized,  x  70,000. (b) Note immunogold label along the inner granule membrane (arrows) which is cleaved on frozen thin 
sections in a manner similar to freeze-fractured  membranes, x  70,000. (c) Label is present along both alpha-granule membranes 
(arrows) and along membranes of, as yet, unidentified structures (arrowheads), which may be a-granules with extracted content 
or dense  bodies,  x  70,000.  (d)  Unstimulated  platelets,  fixed,  permeabilized with  saponin,  and  exposed first  to  polyclonal 
antibodies to nondenatured GMP-140 and then to Fab-peroxidase conjugate. Some granules contain reaction product along their 
membranes  (arrowheads),  and  others  are  unlabeled, (g)  possibly  because  of  incomplete  permeabilization of  the  granule 
membranes by saponin. The matrix of these labeled granules is unreactive:  apparently, GMP-140  is confined to the membrane 
of the alpha-granule. The labeled granules are designated as alpha-granules because of their typical size and number.  We rarely 
observe dense  granules in these  frozen thin section  preparations.  Lysosomes and  peroxisomes, which are  revealed  only by 
specific histochemical  stains, are considerably smaller than alpha~granules,  gl,  glycogen; m, mitrochondrion, x  60,000. 
884  THE JOURN^L OF CELL BIOLOGY . VOLUME 101, 1985 FIGURE 5  Frozen thin  section  of thrombin-stimula.ted  (I  U/ml  for 5  min)  platelets  exposed first  to  polyclonal antibodies to 
nondenatured GMP-140 and then to immunogold conjugate.  By this time, degranulation of the alpha-granules into the SCCS has 
occurred and the center (c) of the cell is now occupied by a dense mass of cytoskeletal elements. Note the extensive label along 
the plasma membranes (arrowheads) and the widened channels of the SCCS (asterisks). x  48,000. 
has SDS PAGE analysis of  the dense granule membranes been 
reported. The technique of subcellular fractionation has the 
significant  drawback  that  one  membrane  fraction  may be 
contaminated with another.  None of these studies involved 
immunocytochemical analysis: Therefore, we believe that we 
have provided the first well-documented example of a platelet 
glycoprotein confined to a secretory-granule membrane in the 
unstimulated  cell.  Recently,  Buckley  and  Kelly (21)  have 
characterized a  transmembrane glycoprotein specific for se- 
cretory vesicles of neural and endocrine cells. 
After platelets have been stimulated with thrombin, GMP- 
140 is redistributed to the SCCS and plasma membrane. We 
showed  previously that  after thrombin  stimulation,  alpha- 
granules coalesce, then fuse with membranes of the SCCS (8). 
The proteins packaged in the granules are then released to the 
exterior of the cell, where at least some of the molecules bind 
to  the  platelet surface by Ca++-dependent interactions  (see 
diagram in  reference 22).  These membrane-bound proteins 
may play important roles in hemostasis (2, 8). Although the 
results reported here were obtained from platelet suspensions 
stimulated with thrombin for 5 min, studies are underway to 
examine shorter periods. This will enable us to determine the 
pattern  of GMP-140  redistribution  after  stimulation  from 
early time points to  the  point  of maximal change.  At  low 
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external S12  monoclonal antibody before significant release 
of [t4C]serotonin (4). This is consistent with the observation 
that release of alpha-granule proteins occurs at lower throm- 
bin concentrations than does secretion of dense granule sub- 
stances such as serotonin (23). GMP-140  presumably redis- 
tributes throughout the SCCS and plasma membranes after 
alpha-granule membranes fuse with SCCS  membranes.  We 
cannot exclude the possibility that GMP-140 clusters in dis- 
crete regions of the plasma membrane or the SCCS  mem- 
branes. Resolution of this question will require immunocy- 
tochemical procedures that  allow the visualization of large 
regions of the cell surface. 
Membrane proteins in adrenal chromaffin granules, which 
are exposed  on the cell  surface after exocytosis,  are subse- 
quently  internalized,  presumably  to  be  recycled  into  new 
secretory-granule membranes (24-26). Time-course studies of 
washed platelets indicate that the number of S 12 binding sites 
present on the platelet plasma membrane remains constant 
from  10  to  60  min  after  thrombin  stimulation  at  37"C 
(George, J. N., and R. P. McEver, unpublished observations). 
This suggests that GMP-140  may not recycle after platelet 
secretion, although we cannot yet exclude such a possibility 
in platelets circulating in vivo. 
The function of this platelet granule membrane protein is 
unknown. Since antibody binding studies indicate that there 
are  ~10,000  molecules  on  the  plasma  membrane  of each 
stimulated cell, GMP-140  appears to be a major component 
of platelet alpha-granule membranes and might play an im- 
portant role in hemostasis. Even platelets from patients with 
the gray platelet syndrome have substantial amounts of im- 
munoreactive GMP-140  (Rosa, J. P., R. P. McEver, and A. 
T. Nurden, unpublished observations). This may be explained 
by recent findings (27) that such platelets contain a population 
of abnormal small alpha-granules that are not identifiable by 
routine transmission electron microscopy. In addition to in- 
vestigating the function of GMP-140,  determining its local- 
ization  in  the  human  bone  marrow  megakaryocytes from 
which  platelets  are  derived  will  be  of great  interest.  Such 
studies may help to identify regions involved in membrane 
protein  sorting  and  organelle  formation  in  these  unusual 
polyploid cells. 
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